CDC: No Unexpected Side Effects Reported With Third COVID-19 Vaccine Dose
During the period of August 12 to September 19, 2021, a total of 22,191 individuals reported receiving an additional dose of a COVID-19 vaccine.
All articles by Diana Ernst, RPh
Tibsovo Approved for IDH1-Mutated Cholangiocarcinoma
The approval was based on data from the double-blind, placebo-controlled ClarIDHy study.
ACIP: Updated Vaccine Guidance for the 2021-2022 Influenza Season
Routine annual vaccination is recommended for all patients 6 months of age and older who have no contraindications.
Linzess Labeling Updated Based on New Pediatric Data
The updated label now states that the treatment is contraindicated in patients less than 2 years of age due to the risk of serious dehydration.
CDC: COVID-19 Vaccination Recommended for Pregnant People
The recommendation aligns with that from the American College of Obstetricians and Gynecologists and the Society for Maternal Fetal Medicine.
Baricitinib Alone Authorized for COVID-19 Under Revised EUA
The update was based on data from the COV-BARRIER study.
CDC Reverses Course on Masks for Fully Vaccinated in Light of SARS-CoV-2 Variants
The CDC also issued a health advisory about the urgent need to increase COVID-19 vaccination coverage.
FDA Takes Steps to Maintain Supply of Smoking Cessation Therapy
N-nitroso-varenicline may be associated with an increased cancer risk based on data from closely related nitrosamine compounds.
New-Onset SVT Following Colonoscopy Bowel Prep Explored in Case Series
A significant percentage of affected patients were observed to have dilated atria and left ventricular hypertrophy.
Wegovy Approved for Chronic Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist.
- Loading...
Loading...
Next post in General Gastroenterology
Loading... 
Loading...